Protalix BioTherapeutics, Inc. | 2013 | FY | 3


Options granted to consultants, directors, and other service providers:

 

    Year ended December 31,  
    2011     2012     2013  
          Weighted           Weighted           Weighted  
    Number     average     Number     average     Number     average  
    of     exercise     of     exercise     of     exercise  
    options     price     options     price     options     price  
Outstanding at beginning of year     1,438,692     $ 4.697       1,238,692     $ 5.385       912,425     $ 7.259  
Changes during the year-Exercised (*)     200,000       0.001       326,267       0.12                  
Outstanding at end of year     1,238,692     $ 5.385       912,425     $ 7.259       912,425     $ 7.259  
Exercisable at end of year     1,235,567     $ 5.385       912,425     $ 7.259       912,425     $ 7.259  

(*) The total intrinsic value of options exercised during the years ended December 31, 2011 and 2012, was approximately $1.9 million, and $2.3 million, respectively.

 


us-gaap:ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionBySupplierTextBlock